Cure My Disease

Don't miss your cure!

 Log in / Sign up

A 5-Minute ultrasound could reveal how sick a Baby's lungs really are

NCT ID NCT07778225

Diagnosis Sponsor: Eskisehir Osmangazi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study tests whether a quick, bedside ultrasound of the internal jugular vein in the neck can help tell how severe bronchiolitis is in infants aged 1 to 23 months. Researchers will measure how much the vein's diameter changes with breathing and compare that to standard clinical severity scores, oxygen levels, and need for intensive care. No treatment is given—the ultrasound is added to usual care to see if it can serve as a reliable marker of disease severity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Point-of-care ultrasonography (POCUS) measuring internal jugular vein diameter variation
What this could lead to
If it works, this could give doctors a quick, non-invasive way to gauge bronchiolitis severity in infants, helping guide treatment decisions.
What could go wrong
This is an observational study, so it can only show a link, not prove cause. The ultrasound technique may not reliably predict severity in all infants, and results may not apply beyond this specific setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Infants aged 1 to 23 months presenting to the Pediatric Emergency Department with a clinical diagnosis of acute bronchiolitis according to the American Academy of Pediatrics (AAP) clinical criteria will be prospectively enrolled. Eligible participants will be evaluated within the first 6 hours of emergency department presentation after written informed consent is obtained from a parent or legal guardian. Participants will undergo standardized clinical severity assessment and point-of-care ultrasonography of the internal jugular vein, lungs, and diaphragm in addition to routine clinical care. No study-specific therapeutic intervention will be assigned.

Ages

1 month to 23 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Infants aged 1-23 months * Clinical diagnosis of acute bronchiolitis per AAP (2014) criteria (first wheezing episode following an upper respiratory infection prodrome, with tachypnea, retractions, and/or crackles) * Written informed consent obtained from parent/legal guardian * Evaluable within the first 6 hours of emergency department presentation Exclusion Criteria: * Underlying congenital heart disease * Chronic lung disease (bronchopulmonary dysplasia, cystic fibrosis) * Prior history of recurrent wheezing/suspected asthma * Anatomical abnormality of the neck or prior history of central venous catheterization or jugular vein thrombosis * Hemodynamic instability/shock * Immediate need for intubation/mechanical ventilation precluding ultrasound assessment * Parent/legal guardian declines consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute bronchiolitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute bronchiolitis bronchiolitis Bronchiolitis, Viral respiratory syncytial virus infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute bronchiolitis Respiratory syncytial virus infections Viral bronchiolitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Eskisehir Osmangazi University Faculty of Medicine, Pediatric Emergency Department

    Eskişehir, Eskişehir, 26480, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.